The Global Hereditary Angioedema Treatment Market to pick up from expanding occurrences of hereditary change. Recently Fortune Business Insights, published a report titled, “Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025.”
As per the report, the global hereditary angioedema treatment market was worth US$ 1883.1 Mn in 2017. The global market is anticipated to expand at a CAGR of 16.8% and reach US$ 6533.3 Mn by the end of 2025. The report classifies the global hereditary angioedema treatment market in various segments and offers a comprehensive overview.
Browse Complete Report Details:
- BIOCRYST PHARMACEUTICALS INC.
- Ionis Pharmaceuticals
- Attune Pharmaceuticals
- Arrowhead Pharmaceuticals
- Other key players
According to the report, the hereditary angioedema treatment market in North America was valued at US$ 1752.2 Mn in 2017. The growth witnessed is attributable to the high prevalence of hereditary angioedema in the region. North America may remain dominant in the global market through the forecast period (2018-2025) also. Presence of an established healthcare system and increasing healthcare expenditure are a few factors anticipated to contribute to the expansion of the hereditary angioedema treatment market in North America.
The report also predicts the market in the Asia Pacific to witness impressive growth. Increasing medical tourism in nations such as China and India will create lucrative growth opportunities for the market in the region. Besides this, an increasing number of product innovations in the region backed by the high presence of hereditary angioedema drugs manufacturers will give tailwinds to the growth witnessed by the hereditary angioedema treatment market.
C-1 Esterase Inhibitor Segment to Dominate Global Market During Forecast Period
In terms of drug class, the C-1 esterase inhibitor is the most popular drug and dominated the global hereditary angioedema treatment market in 2017. The segment accounted for 61.3% of the global market in 2017. The trend is unlikely to change during the forecast period 2018-2025 owing to the drug’s reliability among patients and practitioners.
Increasing awareness about the disorder and rising prevalence of the hereditary angioedema are some factors expected to drive the global hereditary angioedema treatment market during the forecast period. Additionally, technological developments in the hereditary angioedema treatment devices and equipment are expected to boost the global market.
According to the U.S. Hereditary Angioedema Association, hereditary angioedema may not necessarily occur due to the prior familial history of the disease. In 25% of the case, hereditary angioedema may arise due to a spontaneous mutation of the gene called C-1 inhibitor. This is anticipated to enable growth in the global hereditary angioedema treatment market.
On the flip side, the side effects and high cost associated with hereditary angioedema drugs and treatment is the major factor that may restrain the global hereditary angioedema treatment market.
Sample PDF Brochure
Shire, CSL Behring, and Pharming Group NV to Lead the Global Market
The global hereditary angioedema treatment market is witnessing the entry of new players in the market. However, at present Pharming Group NV, the Shire, and CSL Behring are together leading the global market owing to the organization’s strong distribution network.
Some of the other companies operating in the global hereditary angioedema treatment market are BIOCRYST PHARMACEUTICALS INC., Ionis Pharmaceuticals, Attune Pharmaceuticals, Arrowhead Pharmaceuticals, and adverum-biotechnologies.
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
View More Reports: